A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Recruiting · NCT05157763 · Registry updated 2021-12-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma | nodular basal cell carcinoma | Recruiting | Phase 1 / Phase 2 | 2021-12-15 | NCT05157763 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MediWound Ltd | 4 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center for Clinical and Cosmetic Research | Aventura | United States | 6 |
| Center for Clinical Studies, LTD. LLP | Webster | United States | 3 |
| Moore Clinical Research, Inc. | Brandon | United States | 1 |